SmithCM. Origin and uses of primum non nocere—Above all, do no harm! J Clin Pharmacol, 2005;45(4):371–377.
2.
European Medical Agency. Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. ICI Harmonised Tripartite Guideline. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-15.pdf [Last accessed: March 10, 2023].
3.
BiswasA, OhPI, FaulknerGE, et al.Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: A systematic review and meta-analysis. Ann Intern Med, 2015; 162(2):123–132.
4.
ChauJY, Reyes-MarcelinoG, BurnettAC, et al.Hyping health effects: A news analysis of the ‘new smoking’ and the role of sitting. Br J Sports Med, 2019; 53(16):1039–1040.
5.
SonawaneKB, ChengN, HansenRA. Serious adverse drug events reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006–2014 database. J Manag Care Spec Pharm, 2018; 24(7):682–690.
6.
MakaryMA, DanielM. Medical error—The third leading cause of death in the US. BMJ, 2016; 353:i2139.
7.
CramerH, WardL, SaperR, et al.The safety of yoga: A systematic review and meta-analysis of randomized controlled trials. Am J Epidemiol, 2015; 182(4):281–293.
8.
LambertD, van den BergNH, MendrekA. Adverse effects of meditation: A review of observational, experimental and case studies. Curr Psychol, 2023; 42(2):1112–1125.
9.
HöxtermannMD, HallerH, AboudamaahS, et al.Safety of acupuncture in oncology: A systematic review and meta-analysis of randomized controlled trials. Cancer, 2022; 128(11):2159–2173.
10.
YaoY, LiuZ, ZhangH, et al.Serious adverse events reporting in phase III randomized clinical trials of colorectal cancer treatments: A systematic analysis. Front Pharmacol, 2021; 12:754858.